Loading analysis...
Loading Truth Social...
Loading live updates...
—
S&P 500— —
Nasdaq— —
Dow Jones— —
载入时间机器…
Recent AZN News Headlines
Latest news coverage for AZN aggregated from WSJ, Bloomberg, The New York Times, Financial Times, and Google News. Real-time updates, free and ad-free.
- AstraZeneca wins EU label expansion for Trixeo in asthma (AZN)
- AstraZeneca's Trixeo Secures Approval for Asthma in the EU
- REG - AstraZeneca PLC - Trixeo approved in EU for asthma
- AstraZeneca (LSE:AZN) Stock May Be 48% Undervalued On Enhertu Trial Progress
- Astrazeneca (AZN) Ascends But Remains Behind Market: Some Facts to Note
- Can AstraZeneca's Broad Pipeline Offset Recent Setbacks?
- AstraZeneca (LSE:AZN) Reported First HER2 Directed Lung Cancer Phase III Success
- AstraZeneca (AZN)’s Lung Drug Delivers the Good News its Pipeline Needed
- AstraZeneca (AZN) Wins FDA Approval for its Breast Cancer Pill After Regulators Voiced Doubts
- Transcript: AstraZeneca Q2 2026 Earnings Conference Call
- Is It Worth Investing in Astrazeneca (AZN) Based on Wall Street's Bullish Views?
- AstraZeneca's news flow next year could sustain drugs group beyond 2030, says leading bank
- AstraZeneca’s Oncology Engine Faces a Key Test After Camizestrant Miss
- REG - AstraZeneca PLC - Director/PDMR Shareholding
- AstraZeneca, Leidos, Expeditors International And More On CNBC’s ‘Final Trades’
AZN options: max pain, gamma exposure (GEX) & key levels · Search AZN in the news archive · All tickers
Settings
Appearance
Card Style
Language
Notifications
Live View Style
Trump Truth Social
About
Version
2.6.1
Data Source
r/wallstreetbets
AI Engine
ChatGPT/Gemini/Claude
MCP Server
https://mcp.sellthenews.org/mcp
Contact Us
[email protected]